Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
MMWR. Morbidity and Mortality Weekly Report|November 3, 2022
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
Vaccine|July 31, 2016
High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responsesJin Hyang Kim, H Keipp Talbot, Margarita Mishina, et al.
The New England Journal of Medicine|May 2, 2003
Effectiveness of pneumococcal polysaccharide vaccine in older adultsLisa A Jackson, Kathleen M Neuzil, Onchee Yu, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Vaccine|October 7, 2014
Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?James G Donahue, Burney A Kieke, Peter G Szilagy, et al.
Pediatrics|December 10, 2014
Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011Astride Jules, Carlos G Grijalva, Yuwei Zhu, et al.
Pageof 16